文献速递围术期管理与 ERAS

撒哈拉以南非洲国家层面扩大WHO手术安全核查表的经济学论证

Economic Case for Scale-up of the WHO Surgical Safety Checklist at the National Level in Sub-Saharan Africa.
PubMed 文献 · Ann Surg · 2020-09-15

该研究基于贝宁、喀麦隆和马达加斯加三国数据,评估全国推广WHO手术安全核查表的成本效果与效益成本。结果显示每避免一个生命损失年增量成本为31至138国际元,效益成本比为9至62,符合WHO「极具成本效果」标准。

要点

  • 三国ICER为每避免一个YLL增量成本31、138、118国际元。
  • 三国效益成本比分别为62、29、9,每投入1美元潜在回报9至62美元。
  • 敏感性分析显示死亡 reduction 和使用率需偏离约10倍才改变主要结论。

核心结论

  • 按WHO标准,扩大核查表推广「极具成本效果」,每花费1美元潜在投资回报为9至62美元。
  • 结果与其他健康和非健康干预相比具有优势,支持将核查表推广作为国家改善手术结局战略的投资。

研究设计与样本

  • 基于贝宁、喀麦隆和马达加斯加三国数据的经济学评价,采用成本效果分析和效益成本分析。
  • 效益以3年期间避免的术后死亡所致总生命损失年(YLL)估算,并转换为美元等值。

主要发现

  • 贝宁、喀麦隆和马达加斯加的ICER分别为每避免一个YLL增量成本31、138、118国际元。
  • 贝宁、喀麦隆和马达加斯加的效益成本比分别为62、29、9。
  • 敏感性分析表明相关死亡率下降和核查表使用率增加需偏离已发表数据约10倍才能改变主要解读。

关键数值与推荐

  • 成本以2016年价格水平的国际元报告,采用世界银行购买力平价转换因子。
  • 按WHO标准,核查表推广被认为「极具成本效果」。
  • 每花费1美元潜在投资回报为9至62美元。

临床怎么用

  • 可将核查表全国推广作为改善手术结局的国家战略组成部分进行投资论证。
  • 经济学证据支持在资源有限环境中优先推广WHO手术安全核查表。

局限性

  • 研究仅基于贝宁、喀麦隆和马达加斯加三国数据,外推需谨慎。
  • 效益估算依赖已发表的死亡率下降和使用率增加数据,敏感性分析显示需约10倍偏差才改变结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the economic case for nationwide scale-up of the World Health Organization (WHO) Surgical Safety Checklist using cost-effectiveness and benefit-cost analyses. BACKGROUND: The Checklist improves surgical outcomes but the economic case for widespread use remains uncertain. For perioperative quality improvement interventions to compete successfully against other worthwhile health and nonhealth interventions for limited government resources they must demonstrate cost-effectiveness and positive societal benefit. METHODS: Using data from 3 countries, we estimated the benefits as the total years of life lost (YLL) due to postoperative mortality averted over a 3 year period; converted the benefits to dollar equivalent values using estimates of the economic value of an additional year of life expectancy; estimated total implementation costs; and determined incremental cost-effectiveness ratio (ICER) and benefit-cost ratio (BCR). Costs are reported in international dollars using Word Bank purchasing power parity conversion factors at 2016 price-levels. RESULTS: In Benin, Cameroon, and Madagascar ICERs were: $31, $138, and $118 per additional YLL averted; and BCRs were 62, 29, and 9, respectively. Sensitivity analysis demonstrated that the associated mortality reduction and increased usage due to Checklist scale-up would need to deviate approximately 10-fold from published data to change our main interpretations. CONCLUSIONS: According to WHO criteria, Checklist scale-up is considered "very cost-effective" and for every $ 1 spent the potential return on investment is $9 to $62. These results compare favorably with other health and nonhealth interventions and support the economic argument for investing in Checklist scale-up as part of a national strategy for improving surgical outcomes.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. White MC, Leather AJM, Sevdalis N, et al. Economic Case for Scale-up of the WHO Surgical Safety Checklist at the National Level in Sub-Saharan Africa. Ann Surg. 2020. PMID: 32941283. doi:10.1097/SLA.0000000000004498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。